Therefore, targeting RAGE, HMGB1, and S100A8/A9 will not only reduce immune suppression and facilitate antitumor immunity but may also delay tumor progression by neutralizing the many other mechanisms by which these molecules promote tumor growth. This evidence concerns the gene S100A8 and neoplasm.